跳至主要内容
临床试验/EUCTR2008-001319-39-IT
EUCTR2008-001319-39-IT进行中(未招募)不适用

PROtection of coronary Microcirculation by Iloprost:Safety and Efficacy in Percutaneous Coronary Intervention - PROMISE PCI

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 个研究点开始时间: 2008年7月8日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion Criteria
  • 1.Age > 18 y
  • 2.Stable angina or inducible ischemia
  • 3.Acute myocardial infarction without ST elevation (NSTEMI)
  • 4.Planned angioplasty on one, two or three coronary lesions
  • 5.Informed Consent
  • Subgroup with coronary flow study
  • Acute myocardial infarction without ST elevation (NSTEMI)
  • Planned angioplasty on only one stenosis or on double lesion on single vessel
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion Criteria
  • 1.Atrial fibrillation (cases with coronary flow study)
  • 2.ST elevation acute myocardial infarction (STEMI)
  • 3.Contraindications to anti-platelet therapy or IIb/IIIa inhibitors
  • 4.Hypertension (> 180/100 mmHg)
  • 5.Planned angioplasty on more than three coronary stenoses
  • 6.Two or more of the following procedural characteristics: stenoses in coronary bifurcations, multiple stenoses, stenoses in saphenous aorto-coronary grafts
  • 7.Pregnancy or fertile age
  • Subgroup with coronary flow study
  • Atrial fibrillation
  • Proximal tortuosity of the vessel

研究者

发起方
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

相似试验

进行中(未招募)
不适用
PROtection of coronary Microcirculation by Iloprost:Safety and Efficacy evaluation in PCI - PROMISEcoronary angioplastyMedDRA version: 9.1Level: LLTClassification code 10050329Term: Coronary angioplasty
EUCTR2006-002726-32-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
进行中(未招募)
1 期
Protective effect of antiplatelet drug Ticagrelor compared to antiplatelet drug Clopidogrel on small heart vessels in diabetic patient with anginaIschemic Heart Disease in Diabetic patientsMedDRA version: 18.1 Level: PT Classification code 10072685 Term: Microvascular coronary artery disease System Organ Class: 10007541 - Cardiac disorders
EUCTR2015-003621-33-ESFundación Interhospitalaria de Investigación Cardiovascular50
进行中(未招募)
不适用
Influence on the coronary Microcirculation and on myocArdial perfusion Reserve of Niaspan given IN addition to simvastatin in diabEtic patients - MARINE
EUCTR2006-000569-13-DECardioangiologisches Centrum Bethanien40
进行中(未招募)
不适用
PROMISE AMI (PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy evaluation in Acute Myocardial Infarction treated by primary PCI) Pilot Study - Promise AMIAcute myocardial infarction
EUCTR2008-001325-34-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
已完成
不适用
Coronary Microcirculatory and Bioresorbable Vascular ScaffoldsCHD - Coronary Heart DiseaseAngina, StableMyocardial Ischemia
NCT03076476Papworth Hospital NHS Foundation Trust36